Three absurdly cheap dividend stocks that are trading at modest multiples of their expected earnings today are Merck (NYSE: ...

FOLD and EDIT are in the spotlight following patent dispute settlement news and strategic updates, respectively.

The healthcare sector has been a focal point for investors in 2024, offering a compelling blend of innovation-driven ...

Amgen's move follows the lifting of a temporary injunction on the launch of its Pavblu-branded biosimilar by the US Court of ...

A new national research hub will position the UK as a world leader in the emerging global field of long-acting therapeutics ...

Here we pay tribute to stars of TV, film, music, sport, and politics who have left us during 2024. The year started with the ...

A local community-based organization has submitted documents to launch a program aimed at drug-related harm reduction in Santa Cruz County, and time is running out for the public to comment on the ...

In moving the NHS from broken to “fixed” (doi:10.1136/bmj.q2309),1 the focus is on three shifts identified in the Darzi ...

The brain has GLP -1 receptors in abundance and, though very little drug seems to be able to cross the blood-brain barrier ...

The AHA Oct. 24 announced it has been awarded a nearly $1.5 million grant from the Centers for Disease Control and Prevention ...

Results showed treatment with Dupixent significantly reduced itch and urticaria ... added to standard-of-care histamine-1 (H1) antihistamines. At 24 weeks, Dupixent demonstrated significant ...

Expanding access to cutting-edge diabetes and weight-loss drugs like Ozempic and Zepbound could prevent more than 42 ...